A Study of Modakafusp Alfa Together With Daratumumab Adults With Relapsed or Refractory Multiple Myeloma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
The main aim of this study is to determine safety and tolerability of modakafusp alfa given together with daratumumab to find out the best treatment dose. Another aim of this study is to learn more about the characteristics of modakafusp alfa.
Epistemonikos ID: 0a1b19de271bc5e4907df0e5e74e5d3480393367
First added on: May 14, 2024